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Abstract. Brain oxidative processes play a major role in age-related cognitive decline, thus consumption of antioxidant-rich
foods might help preserve cognition. Our aim was to assess whether consumption of antioxidant-rich foods in the Mediterranean
diet relates to cognitive function in the elderly. In asymptomatic subjects at high cardiovascular risk (n = 447; 52% women;
age 55–80 y) enrolled in the PREDIMED study, a primary prevention dietary-intervention trial, we assessed food intake and
cardiovascular risk profile, determined apolipoprotein E genotype, and used neuropsychological tests to evaluate cognitive
function. We also measured urinary polyphenols as an objective biomarker of intake. Associations between energy-adjusted food
consumption, urinary polyphenols, and cognitive scores were assessed by multiple linear regression models adjusted for potential
confounders. Consumption of some foods was independently related to better cognitive function. The specific associations
[regression coefficients (95% confidence intervals)] were: total olive oil with immediate verbal memory [0.755 (0.151–1.358)];
virgin olive oil and coffee with delayed verbal memory [0.163 (0.010–0.316) and 0.294 (0.055–0.534), respectively]; walnuts with
working memory [1.191 (0.061–2.322)]; and wine with Mini-Mental State Examination scores [0.252 (0.006–0.496)]. Urinary
polyphenols were associated with better scores in immediate verbal memory [1.208 (0.236–2.180)]. Increased consumption of
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antioxidant-rich foods in general and of polyphenols in particular is associated with better cognitive performance in elderly
subjects at high cardiovascular risk. The results reinforce the notion that Mediterranean diet components might counteract
age-related cognitive decline.
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INTRODUCTION
Increased lifespan in developed countries has
resulted in a greatly raised frequency of diseases
related to aging, such as cardiovascular and neurode-
generative disorders, including Alzheimer’s disease
(AD), the most common type of dementia [1]. AD
is characterized by cognitive deterioration with a
progressive impairment of activities of daily living.
Cognitive changes, however, are not particular to
severe neurodegenerative diseases like AD, as the
aging process naturally entails normal age-associated
cognitive decline. The cognitive functions that are most
frequently affected with aging are memory, especially
codification, recall, and working memory, and execu-
tive functions that imply information processing speed,
divided attention, and planning [2].
Factors recognized to aid in maintaining cognitive
performance include years of schooling, professional
achievement, social engagement, and physical activ-
ity [3]. Such factors are encompassed in the concept
of cognitive reserve, described as the brain’s capacity
to compensate for neuropathological damage in brain
aging, making clinical symptoms unobtrusive or even
imperceptible [4]. An appealing link hypothesized in
recent years is the association between lifestyle habits,
particularly food patterns, and cognitive reserve [3,
5]. Epidemiological studies suggest that foods such
as fruits, vegetables, fish, and wine and nutrients such
as polyunsaturated fatty acids, E and B-vitamins, and
antioxidants might protect from age-related cognitive
decline, mild cognitive impairment (MCI) and AD
[6–10]
Nutritional epidemiology has evolved beyond nutri-
ents and foods, with increasing recognition of the
importance of dietary patterns, in which synergy exists
among food constituents, with additive effects on
health [11, 12]. One such pattern is the traditional
Mediterranean diet, a reputed model of healthy eat-
ing that is characterized by a high consumption of
foods and nutrients presumed to be healthy for the
brain, such as vegetables, fruits, fish, unsaturated
fatty acids, and diverse antioxidants, with moderate
intake of alcoholic beverages, mostly wine [13]. Both
prospective and clinical studies report that greater
adherence to a Mediterranean-type diet is associated
with a reduced incidence of coronary heart disease
(CHD) [13–15]. Consistently, epidemiological studies
point to a reduction in the incidence of and mortality
from cardiovascular diseases [13, 15, 16] and cancer,
which results in increased longevity [16]. Importantly,
as recently reviewed [17], increasing compliance with
Mediterranean-type diets has also been associated with
slower cognitive decline [18], a reduction in the inci-
dence of MCI [19], neurodegenerative disorders such
as Parkinson’s disease [20] and AD [21, 22], and mor-
tality attributable to AD [23, 24].
Oxidative stress and ensuing inflammation are
believed to play major roles in the pathogenesis of
age-related diseases, including cognitive impairment
and AD. They also are ideal targets for nutritional inter-
vention with antioxidants, for which the Mediterranean
diet is particularly well suited [25]. Therefore, we eval-
uated in a cross-sectional study whether consumption
of antioxidant-rich foods from the Mediterranean diet
was associated with better cognitive performance in a
cohort of elderly persons at high risk for CHD living
in Spain, a Mediterranean country. In addition, since
there is evidence that consumption of flavonoids, a
subclass of polyphenols, positively relates to cogni-
tive function [26], we complemented dietary data with
urinary polyphenol excretion, an objective biomarker
of phenol intake.
METHODS
Participants and design of the study
The study population was drawn from the
cohort of the PREDIMED (PREvencio´n con DIeta
MEDiterra´nea) study, a clinical trial in asymp-
tomatic persons at high cardiovascular risk testing
the Mediterranean diet for outcomes on cardio-
vascular disease events (http://www.predimed.org;
ISRCTN35739639). The design of the PREDIMED
study has been described in detail elsewhere [27]. Can-
didates were community-dwelling men aged 55–80
years and women aged 60–80 years, without prior car-
diovascular disease but having a prior diagnosis of
diabetes or at least three cardiovascular risk factors,
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namely smoking, hypertension, dyslipidemia, over-
weight (body mass index [BMI] ≥25 kg/m2), and
family history of premature cardiovascular disease
(≤55 years in men and ≤60 years in women). Other
exclusion criteria were any severe chronic illness, alco-
hol or drug abuse, or BMI ≥40 kg/m2. Participants
fulfilling inclusion criteria and not meeting exclu-
sion criteria provided informed consent to a protocol
approved by the local review board and underwent
various tests, including venipuncture to obtain fasting
blood and collection of a spot urine sample.
Anthropometric and blood pressure measurements
were performed by standard methods, as previously
described [27]. Smoking status was categorized into
never, current or past smoking according to self-
reports. Physical activity was assessed with the
validated Spanish version of the Minnesota question-
naire and expressed in minutes at a given metabolic
equivalent (MET-min) per day [28]. Dietary data
related to self-selected food intake during the previ-
ous year were collected during a face-to-face interview
with a single trained dietitian using a validated 137-
item food-frequency questionnaire (FFQ) [29] and
converted to daily intakes. Energy and nutrient intake
were calculated from Spanish food composition tables.
The apolipoprotein E (APOE) genotype was deter-
mined by using the method of Hixson and Vernier
[30]. High-sensitivity C-reactive protein (CRP) was
measured using an immunoturbidimetric technique.
Total polyphenols in spot urine samples were deter-
mined with the Folin-Ciocalteu assay after solid phase
extraction, together with the creatinine concentra-
tion, as described [31]. Total polyphenol excretion
was expressed as mg of gallic acid equivalents
(GAE)/g of creatinine. Urinary total polyphenol excre-
tion expressed by 24-h volume is a better biomarker
of polyphenol dietary intake than expressed by uri-
nary creatinine normalization. However, when total
volume in 24-h is not available, creatinine-corrected
urinary total polyphenol excretion may also be a suit-
able biomarker of total polyphenols in a free-living
population [32].
From October 2004 to December 2009, 578 con-
secutive persons entering the PREDIMED study in the
recruiting centre located at Hospital Clı´nic (Barcelona,
Catalonia, Spain) were asked to submit to neuropsy-
chological testing to assess cognitive function. During
the screening visit, participants were asked about edu-
cation years and information about exclusion criteria
specific for this substudy was sought, namely depres-
sion, as assessed by the Hamilton Depression Rating
Scale (participants with a score >13 were excluded)
[33], severe cognitive impairment, defined by a score
<25 in the Mini-Mental State Examination (MMSE)
[34], illiteracy, or difficulty in expression or compre-
hension of Spanish language.
Cognitive assessment
An experienced neuropsychologist who was blinded
to the subjects’ diet and cardiovascular risk factors
conducted the cognitive examination. The instruments
used were the MMSE to assess global cognitive
function [34]; the Rey auditory verbal learning test
(RAVLT) to rate immediate (sum of words recalled
on the five learning trials) and delayed episodic ver-
bal memory [35]; the verbal paired associates test, a
subtest of Wechsler Memory Scale (WMS) [36], to
evaluate episodic memory performance; the semantic
verbal fluency test [37]; the digit span test of the Wech-
sler Adult Intelligence Scale (WAIS) [38] to assess
immediate memory (direct digits) and working mem-
ory (reverse order digits); and the Color Trail Test (part
I and II) [39] to measure executive function, including
attention, visual-motor speed, and cognitive flexibility.
Statistical analyses
We fitted multiple linear regression models to assess
independent associations of demographic, clinical, and
dietary variables and urinary polyphenol excretion
with neuropsychological test scores. In the first model,
with cognitive test scores as dependent variables, we
introduced the energy-adjusted intakes of various food
groups (cereals, vegetables, fruits, legumes, nuts, meat
and meat products, seafood, olive oil, alcohol, and cof-
fee) as independent variables. In the second model we
adjusted for age, gender, education years, BMI, current
smoking, physical activity, APOE genotype, diabetes,
hypertension and hyperlipidemia, and the food groups
that were significantly associated with test scores in the
first model as potential confounders. Because in addi-
tion to questions on intake of total alcohol, olive oil,
and nuts, the FFQ used in the study contains specific
questions on intake of wine, virgin olive oil (VOO),
and walnuts, we constructed additional models where
alcohol, olive oil, and nut consumption were replaced
by wine and other alcoholic beverages, VOO and
common olive oil, and walnuts and other nuts, respec-
tively. In a further model, we entered as independent
variable urinary polyphenol excretion alone, to avoid
collinearity with other antioxidant-rich food groups,
with adjustment for the same variables plus total energy
intake. Finally, the logarithmical transformed values
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of urinary polyphenol excretion and serum CRP were
entered in a partial correlation adjusted by gender, age
and BMI. p values <0.05 were considered significant.
SPSS software, version 16.0 (SPSS Inc., Chicago, IL)
was used for statistical analyses.
RESULTS
Characteristics of participants
Figure 1 shows the flow of participants. By study
design, there was a high prevalence of cardiovascular
risk factors in the 447 participants available for analysis
(Table 1).
As shown in Table 2, the self-selected participant’s
dietary habits reasonably conformed to the traditional
Mediterranean food pattern in several aspects, as they
recorded high intakes of cereals, vegetables, fruits, fish,
and olive oil and moderate intakes of legumes, nuts,
and wine. They deviated from the traditional Mediter-
ranean diet, however, because of high intakes of meat
and dairy products. The extreme ranges underscore the
high between-subject variability of energy and food
intake and urinary polyphenol excretion.
Cognitive performance
Various clinical, demographic and dietary variables
were independently associated with the outcomes of
neuropsychological tests by multiple linear regression
analyses after adjustment for various confounders. The
fully adjusted associations are shown in Table 3. Older
age, diabetes, and hypertension were associated with
lower MMSE scores, while higher education years and
higher wine intake were associated with better perfor-
Declined to participate
Did not meet inclusion criteria
Had incomplete testing, missing
food data or energy intake 
outside pre-specified ranges 
578
33
545
58
487
40
447
Fig. 1. Flow chart of participants.
Table 1
Socio-demographic and anthropometric characteristics, physical
activity, cardiovascular risk factors and APOE genotype of the study
population (n = 447)
Variables Mean or median Range
Age (years) 66.9 (54.7–80.2)
Women, n (%) 233 (52.1)
Education (years) 7.18 (0–14)
Body mass index (kg/m2) 28.5 (18.8–36.8)
Leisure-time physical
activity (Kcal/d) 235* (0–1382)
Home physical activity (Kcal/d) 179* (0–1755)
Energy expenditure
in physical activity (MET-min/d) 492* (0–2028)
Family history of
early-onset CVD, n (%) 133 (29.8)
Smoking, n (%) 72 (16.1)
Diabetes, n (%) 250 (55.9)
Antidiabetic medication, n (%) 180 (72.0)
Hyperlipidemia, n (%) 322 (72.0)
Lipid-lowering agents, n (%) 218 (67.7)
Hypertension, n (%) 336 (75.2)
Antihypertensive medication, n (%) 296 (88.1)
APOE 4 genotype, n (%)† 79 (17.8)
Serum C-reactive protein (mg/l) 0.48 (0.01–9.95)
Total polyphenol excretion
(mg GAE/g Cr)‡ 136 (31–773)
*Median. †Sum of E4/3 and E4/4 genotypes (E2/4 excluded).
‡GAE/g Cr, gallic acid equivalents (GAE)/g of creatinine. Abbre-
viations: MET-min, minutes at a given metabolic equivalent level
(units of energy expenditure in physical activity, 1 MET-min
roughly equivalent to 1 Kcal); CVD, cardiovascular disease; APOE,
apolipoprotein E.
Table 2
Daily intake of energy and food groups of the study population
(n = 447)
Variables Mean or median Range
Total energy (Kcal/d) 2362 (1066–3898)
Cereals/grains (g/d) 252 (0–704)
Vegetables (g/d) 406 (0–1480)
Legumes (g/d) 19 (0–103)
Fruits (g/d) 470 (0–1190)
Total nuts (g/d) 5.13 (0–60)
Walnuts (g/d) 1.10 (0–30)
Meat and meat products (g/d) 89 (2–229)
Fish and seafood (g/d) 114 (7–427)
Dairy products (g/d) 359 (0–1367)
Total olive oil (ml/d) 38 (0–75)
Virgin olive oil (ml/d) 4* (0–70)
Total alcohol (g/d) 4* (0–92)
Wine (ml/d) 21* (0–702)
Coffee (ml/d) 21* (0–350)
∗Median.
mance. In the immediate recall of RAVLT, older age
and cereal intake were associated with lower scores.
Conversely, higher education years, the female gen-
der, and higher intake of total olive oil were associated
with immediate verbal memory. Intake of coffee and
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Table 3
Independent associations of cognitive test scores with food intake by multiple linear regression
Neuropsychological test Independent variables Regression coefficient * p
(95% confidence interval)
MMSE Wine per 200 ml/d 0.252 (0.006 to 0.496) 0.096 0.044
Age per 10 years −0.405 (−0.624 to −0.186) −0.170 <0.001
Education per 5 years 0.529 (0.324 to 0.734) 0.238 <0.001
Diabetes −0.289 (−0.553 to −0.025) −0.104 0.032
Hypertension −0.419 (−0.717 to −0.121) −0.132 0.006
RAVLT Total olive oil per 10 g/d 0.755 (0.151 to 1.358) 0.109 0.014
(immediate recall) Cereals per 40 g/d −0.431 (−0.823 to −0.038) −0.098 0.032
Age per 10 years −5.079 (−6.454 to −3.704) −0.329 <0.001
Gender (women) 2.549 (0.932 to 4.165) 0.142 0.002
Education per 5 years 3.304 (2.045 to 4.562) 0.231 <0.001
RAVLT (delayed recall) Virgin olive oil per 10 g/d 0.163 (0.010 to 0.316) 0.094 0.037
Coffee (50 ml/d) 0.294 (0.055 to 0.534) 0.106 0.016
Cereals per 40 g/d −0.235 (−0.379 to −0.091) −0.149 0.001
Meat per 100 g/d −0.845 (−1.556 to −0.135) −0.109 0.020
Age per 10 years −1.606 (−2.108 to −1.105) −0.288 <0.001
Gender (women) 1.443 (0.814 to 2.072) 0.223 <0.001
Education per 5 years 0.838 (0.372 to 1.304) 0.162 <0.001
Hypertension −0.735 (−1.411 to −0.059) −0.098 0.033
Digit span (reverse) Walnuts per 30 g/d 1.191 (0.061 to 2.322) 0.149 0.039
Education per 5 years 0.365 (0.126 to 0.603) 0.220 0.003
Energy expenditure in physical
activity per 100 MET-min/d −0.103 (−0.155 to −0.051) −0.286 <0.001
Cognitive test scores are the dependent variables. The independent variables listed are those showing p < 0.05 after regression analyses.
*: Standardized regression coefficient. Abbreviations: MMSE, Mini Mental State Examination; RAVLT, Rey Auditory Verbal
Learning Test; MET-min, minutes at a given metabolic equivalent level. Variables allowed into the models were gender, age, education,
body mass index, smoking, APOE 4 allele, energy expenditure in physical activity, diabetes, hypertension, and hyperlipidemia.
VOO, higher education years, and the female gen-
der were associated with better performance in the
delayed recall of RAVLT, while older age, hyperten-
sion, and intake of cereals and meat were associated
with lower scores. Total olive oil intake was also
independently associated with the delayed recall of
RAVLT (regression coefficient 0.36, p = 0.001), but
only data on VOO is shown in Table 3 because of
the novelty of the finding. The consumption of wal-
nuts was also associated with better working memory,
as assessed by the reverse digit span test of the WAIS
battery.
Total urinary polyphenol excretion was significantly
and independently associated with the immediate
recall score of RAVLT and nearly significantly with
the delayed recall of RAVLT (Table 4), but not
with the other neuropsychological test. Female gen-
der and higher education years (directly) and age
and diabetes (inversely) also related independently
to RALVT scores. Figure 2 shows that there was a
dose-relationship between urinary polyphenols and
enhancement of the RAVLT score. Moreover, after
adjusting by gender, age, and BMI, we found a
significant albeit weak inverse correlation between
the logarithmically transformed values of total
urinary polyphenol excretion and CRP (r = −0.102,
p = 0.044).
DISCUSSION
In this cross-sectional evaluation of dietary habits
and cognitive function in older persons at high car-
diovascular risk living in a Mediterranean country,
higher intakes of both total olive oil and the virgin
variety of olive oil, coffee, walnuts, and wine were
associated with better memory function and global
cognition. The magnitude of these associations was
variable and they were present in some but not in all
tests of cognitive function, but were independent of
known cognition-related confounders and consump-
tion of other food groups. The findings on VOO
and walnuts, two foods with high antioxidant capac-
ity [40, 41], are novel. Another novel finding is the
independent association of total urinary polyphenol
excretion, an objective biomarker of polyphenol-rich
food intake, with human memory function. Taken
together, these results suggest that antioxidants in
the usual diet might counteract age-related cognitive
decline [6].
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Table 4
Independent associations of cognitive test scores with urinary polyphenols excretion by multiple linear regression analysis
Neuropsychological test Independent variables Regression coefficient * p
(95% confidence interval)
RAVLT (immediate recall) Polyphenol excretion per 100 mg GAE/g Cr 1.208 (0.236 to 2.180) 0.112 0.015
Age per 10 years −5.547 (−6.987 to −4.106) −0.351 <0.001
Gender (women) 2.436 (0.637 to 4.234) 0.133 0.008
Education per 5 years 3.734 (2.423 to 5.045) 0.258 <0.001
Diabetes −1.719 (−3.419 to −0.018) −0.094 0.048
RAVLT (delayed recall) Polyphenol excretion per 100 mg GAE/g Cr 0.357 (−0.004 to 0.719) 0.092 0.053
Age per 10 years −1.673 (−2.209 to −1.137) −0.295 <0.001
Gender (women) 1.343 (0.673 to 2.012) 0.205 <0.001
Education per 5 years 1.037 (0.549 to 1.525) 0.200 <0.001
Diabetes −0.621 (−1.254 to 0.112) −0.095 0.054
Cognitive test scores are the dependent variables. The independent variables listed are those showing P values close to <0.05 after regression
analyses. *: Standardized regression coefficient. Abbreviations: RAVLT, Rey Auditory Verbal Learning Test; GAE/g Cr, gallic acid equivalents/g
of creatinine. Variables allowed in the models were gender, age, education, body mass index, energy intake (Kcal/day), smoking, APOE 4
allele, energy expenditure in physical activity, diabetes, hypertension, and hyperlipidemia.
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Fig. 2. RAVLT scores across quintiles of urinary polyphenol excre-
tion.
Olive oil is a major component of the traditional
Mediterranean diet. It contains abundant monoun-
saturated fatty acids (MUFA), mostly oleic acid,
and, depending on the degree of refinement, variable
proportions of bioactive micronutrients, such as phy-
tosterols, vitamin E, and phenolic compounds [40].
Because of a lower cost, common olive oil (a mix-
ture of refined oil with a small proportion of VOO) is
widely used in Spain in the kitchen and at the table,
while VOO, which is obtained by cold pressing of the
ripe fruit and is much richer in minor but bioactive com-
ponents, has a more restricted consumption, as shown
in our study group (Table 2). Greater consumption of
VOO in the Mediterranean diet has been associated
with various health benefits [40]. Few epidemiologi-
cal studies have related consumption of MUFA with
cognitive function. MUFA is contained in other foods,
for example beef, besides olive oil. This heterogene-
ity in the dietary sources of MUFA might explain why
some results are inconsistent [42–46]. Recently, in line
with our results, a weak association of total olive oil
intake with a reduced risk of cognitive impairment was
reported in a large French cohort [47].
We found that increasing consumption of walnuts,
but not of other nuts, was associated with better work-
ing memory scores. Interestingly, walnuts are among
the foods with highest antioxidant capacity, by far
surpassing other nuts [48]. They are also the whole
food richest in -linolenic acid, the vegetable n-3 fatty
acid [41]. Consistent evidence from prospective studies
suggests that frequent nut intake relates to lower CHD
rates [49]. This may be due in part to the beneficial
effects of nuts on blood lipids [50] and other dis-
ease biomarkers, including oxidation, inflammation,
and endothelial dysfunction [41]. Furthermore, higher
intake of nuts has been related with better cognitive
function and lesser cognitive decline in a prospective
study [51]. Our findings, together with those of a recent
experimental study showing that walnut supplementa-
tion improves both motor and cognitive function in
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aged rats [52], point to the need for further studies on
nuts and cognition.
There is consistent epidemiological evidence that
moderate consumption of alcohol relates inversely to
risk of CHD and total mortality [53]. Among alco-
holic beverages, wine possibly provides additional
cardiovascular benefits because it counteracts oxida-
tive stress through its high polyphenolic content [54].
In our study participants who consumed alcohol were
mostly moderate wine drinkers, and the daily dose
of wine related to a better overall cognitive function
in them. These findings concur with the results of
other studies showing an association of moderate alco-
hol consumption with better cognitive performance
and a reduced risk of neurodegenerative diseases [55,
56].
Because coffee, a beverage with high antioxidant
content, is commonly consumed in European Mediter-
ranean countries, we assessed its association with
cognitive performance. The observed direct associ-
ation with verbal memory is consistent with prior
evidence on the protective effect of caffeine against
development of AD [57].
A common characteristic of the foods directly
related to cognitive performance in our study is their
richness in polyphenols, highly bioactive molecules
with beneficial effects that go beyond the modula-
tion of oxidative stress to improve brain function, at
least in experimental models of aging [58]. Indeed,
urinary polyphenol excretion was independently asso-
ciated with memory performance with a continuous,
dose-related effect. These findings, heretofore not
described, support the validity of the observed asso-
ciations among antioxidant-rich foods and cognition.
Antioxidant-rich foods, but not total polyphenol excre-
tion, have been related to better cognitive performance
also in other clinical studies [6, 26, 59–61]. Further-
more, animals fed antioxidant foods showed improved
cellular signaling and neuronal communication that
translated into better cognitive and motor perfor-
mance [52, 58, 63]. A chronic inflammatory state
promoted by oxidative stress is an integral part of
neurodegenerative diseases. The inverse correlation
between urinary polyphenols and serum CRP observed
in our study is an additional argument in favor of
antioxidant-rich foods. Our results further support the
general theory of oxidative stress as a major driv-
ing force for age-related neurodegenerative processes
[53].
Other variables independently associated with cog-
nitive function in our study, such as gender, age,
education years, diabetes, hypertension, and meat
intake showed relationships in the expected direction
[3, 5], except for those concerning cereal intake and
physical activity. That cereal intake related inversely
to memory function might be due to the fact that
little amounts of whole grains are consumed in
Spain. Refined grains have a high glycemic index
that is associated with insulin resistance, a covariate
of cognitive dysfunction [5]. The inverse association
between physical activity and verbal memory was
unexpected and is difficult to explain. Given the cross-
sectional design of our study, it might be explained
by reverse causation if participants at higher vas-
cular risk, hence more prone to develop impaired
cognition, exercised more following advice of their
caretakers.
Our study has limitations. First, the sample size
is relatively small. Second, given the cross-sectional
design of the study, we cannot exclude the possibility
of reverse causation or residual confounding. Third, the
neuropsychological test battery used does not include
all cognitive functions, although verbal memory, one
of the first areas to be affected with aging, was well
assessed with RAVLT and WMS associated pairs.
Finally, our cohort was at a particularly high vascular
risk, thus the results may not be generalized to the aver-
age elderly population. The study also has strengths,
such as the wide between-subject variability of food
consumption, a comprehensive evaluation of cardio-
vascular risk and dietary intake and, in particular, the
use of urinary polyphenols as an objective biomarker
of intake that is not subject to the possibilities of bias
or inaccurate reporting.
In conclusion, in the context of the Mediterranean
diet, increasing consumption of antioxidant-rich
foods in general and of polyphenols in particular is
associated with better cognitive performance in an
elderly cohort at high cardiovascular risk. The results
reinforce the notion that Mediterranean diet compo-
nents might counteract age-related cognitive decline
[19, 21–23]. While causality cannot be inferred
from results of a cross-sectional assessment such as
the present one, antioxidant-rich foods are known
for many beneficial properties with no harm, thus
they can be recommended to the general public to
promote better health, including probably better
cognitive function. The prospective examination
of the whole cohort of the 6-year PREDIMED
trial will eventually provide firmer evidence
regarding the potential of the Mediterranean diet
to counteract the effects of aging on cognitive decline
and reduce the incidence of neurodegenerative
diseases, including AD.
780 C. Valls-Pedret et al. / Polyphenol-Rich Foods and Cognition in Aging
ACKNOWLEDGMENTS
We thank the PREDIMED participants for their
willingness and enthusiasm to collaborate in the
study and Emili Corbella for providing expert assis-
tance with statistical analyses. CIBERobn and RETIC
RD06/0045 are initiatives of ISCIII, Spain. This
study was supported by PI07-0954 from ISCIII
and GVACOMP2010-181 from Generalitat Valen-
ciana (Prof Corella); AGL2010-22319-C03-01/02/03
(Drs Lamuela-Ravento´s and Medina-Remo´n); FIS
PI 07/0473 and AGL2007-66638-C02-01/02 (Dr
Estruch); PI070240, PI070312, and PI081943 from
ISCIII (Prof Martı´nez-Gonza´lez).
Authors’ disclosures available online (http://www.j-
alz.com/disclosures/view.php?id=1126).
REFERENCES
[1] Ritchie K, Lovestone S (2002) The dementias. Lancet 360,
1759-1766.
[2] Hedden T, Gabrieli JDE (2004) Insights into the ageing mind:
A view from cognitive neuroscience. Nat Rev Neurosci 5,
87-96.
[3] Flicker L (2010) Modifiable lifestyle risk factors for
Alzheimer’s disease. J Alzheimers Dis 20, 803-811.
[4] Stern Y (2002) What is cognitive reserve? Theory and
research application of the reserve concept. J Int Neuropsy-
chol Soc 8, 448-460.
[5] Go´mez-Pinilla F (2008) Brain foods. The effects of nutrients
on brain function. Nat Rev Neurosci 9, 568-578.
[6] Gillette Guyonnet S, Abellan Van Kan G, Andrieu S,
Barberger-Gateau P, Berr C, Bonnefoy M, Dartigues JF, De
Groot L, Ferry M, Galan P, Hercberg S, Jeandel C, Morris
MC, Nourhashemi F, Payette H, Poulaine JP, Portet F, Rous-
sel AM, Ritz P, Rolland Y, Vellas B (2007) IANA task force
on nutrition and cognitive decline with aging. J Nutr Health
Aging 11, 132-152.
[7] Polidori MC, Pratico D, Mangialasche F, Mariani E, Aust O,
Anlasik T, Mang N, Pientka L, Stahl W, Sies H, Mococci
P, Nelles G (2009) High fruit intake is positively correlated
with antioxidant status and cognitive performance in healthy
subjects. J Alzheimers Dis 17, 921-927.
[8] Muldoon MF, Ryan CM, Sheu L, Yao JK, Conklin SM,
Manuck SB (2010) Serum phospholipid docosahexaenonic
acid is associated with cognitive functioning during middle
adulthood. J Nutr 140, 848-853.
[9] Roberts RO, Cerhan JR, Geda YE, Knopman DS, Cha RH,
Christianson TJH, Pankratz VS, Ivnik Rj, O’Connor HM,
Petersen RC (2010) Polyunsaturated fatty acids and reduced
odds of MCI: The Mayo Clinic Study of Aging. J Alzheimers
Dis 21, 853-865.
[10] Mangialasche F, Kivipelto M, Mecocci P, Rizzuto D, Palmer
K, Winblad B, Fratiglioni L (2010) High plasma levels of vita-
min E forms and reduced Alzheimer’s disease risk in advanced
age. J Alzheimers Dis 20, 1029-1037.
[11] Jacobs DR Jr, Gross MD, Tapsell LC (2009) Food synergy:
An operational concept for understanding nutrition. Am JClin
Nutr 89, 1543S-1548S.
[12] Gu Y, Nieves JW, Stern Y, Luchsinger JA, Scarmeas N (2010)
Food combination and Alzheimer disease risk. A protective
diet. Arch Neurol 67, 699-706.
[13] Serra-Majem L, Roman B, Estruch R (2006) Scientific
evidence of interventions using the Mediterranean diet:
A systematic review. Nutr Rev 64, S27-S47.
[14] Mente A, de Koning L, Shannon HS, Anand SS (2009)
A systematic review of the evidence supporting a causal
link between dietary factors and coronary heart disease. Arch
Intern Med 169, 659-669.
[15] Martı´nez-Gonza´lez MA, Garcı´a-Lo´pez M, Bes-Rastrollo M,
Toledo E, Martı´nez-Lapiscina EH, Delgado-Rodrı´guez M,
Va´zquez Z, Benito S, Beunza JJ (2011) Mediterranean diet
and the incidence of cardiovascular disease: A Spanish cohort.
Nutr Metab Cardiovasc Dis 21, 237-244.
[16] Sofi F, Abbate R, Gensini GF, Casini A (2010) Accruing evi-
dence about benefits of adherence to the Mediterranean diet
on health: An updated systematic review and meta-analysis.
Am J Clin Nutr 92, 1189-1196.
[17] Feart C, Samieri C, Barberger-Gateau P (2010) Mediterranean
diet and cognitive function in older adults. Curr Opin Clin
Nutr Metab Care 13, 14-18.
[18] Tangney CC, Kwasny MJ, Li H, Wilson RS, Evans DA, Morris
MC (2011) Adherence to a Mediterranean-type dietary pattern
and cognitive decline in a community population. Am J Clin
Nutr 93, 601-607.
[19] Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N,
Luchsinger JA (2009) Mediterranean diet and mild cognitive
impairment. Arch Neurol 66, 216-225.
[20] Gao X, Chen HL, Fung TT, et al. (2007) Prospective study of
dietary pattern and risk of Parkinson disease. Am J Clin Nutr
86, 1486-1494.
[21] Scarmeas N, Stern Y, Mayeux R, Luchsinger JA (2006)
Mediterranean diet, Alzheimer disease, and vascular medi-
ation. Arch Neurol 63, 1709-1717.
[22] Feart C, Sanieri C, Rondeau V, Amieva H, Portet F, Dartigues
JF, Scarmeas N, Barberger-Gateau P (2009) Adherence to a
Mediterranean diet, cognitive decline and risk of dementia.
JAMA 302, 638-648.
[23] Scarmeas N, Luchsinger JA, Mayeux R, Stern Y (2007)
Mediterranean diet and Alzheimer disease mortality. Neurol-
ogy 69, 1084-1093.
[24] Frisardi V, Panza F, Seripa D, Imbimbo BP, Vendemiale
G, Pilotto A, Solfrizzi V (2010) Nutraceutical properties of
Mediterranean diet and cognitive decline: Possible underlying
mechanisms. J Alzheimers Dis 22, 715-740.
[25] Steele M, Stuchbury G, Mu¨nch G (2007) The molecular basis
of the prevention of Alzheimer’s disease through healthy
nutrition. Exp Gerontol 42, 28-36.
[26] Letenneur L, Proust-Lima C, Le Gouge A, Dartigues JF,
Barberger-Gateau P (2007) Flavonoid intake and cognitive
decline over a 10-year period. Am J Epidemiol 165, 1364-
1371.
[27] Martı´nez-Gonza´lez MA, Corella D, Salas-Salvado´ J, Ros
E, Covas MI, Fiol M, Wa¨rnberg J, Aros F, Ruı´z-
Gutie´rrez V, Lamuela-Ravento´s RM, Lapetra J, Mun˜oz MA,
Martı´nez JA, Sa´ez G, Serra-Majem L, Pinto´ X, Mitjavila
MT, Tur JA, Portillo MD, Estruch R, for the PRED-
IMED Study Investigators (2010) Cohort Profile: Design
and methods of the PREDIMED study. Int J Epidemiol,
doi:10.1093/ije/dyq250.
[28] Elosua R, Marrugat J, Molina L, Pons S, Pujol E (1994)
Validation of the Minnesota Leisure Time Physical Activity
Questionnaire in Spanish men. The MARATHOM Investiga-
tors. Am J Epidemiol 139, 1197-1209.
C. Valls-Pedret et al. / Polyphenol-Rich Foods and Cognition in Aging 781
[29] Ferna´ndez-Ballart JD, Pin˜ol JL, Zazpe I, Corella D, Car-
rasco P, Toledo E, Pe´rez-Bauer M, Martı´nez-Gonza´lez MA,
Salas-Salvado´ J, Martı´n-Moreno JM (2010) Relative valid-
ity of a semi-quantitative food-frequency questionnaire in an
elderly Mediterranean population of Spain. Br J Nutr 103,
1808-1816.
[30] Hixson JE, Vernier DT (1990) Restriction isotyping of human
apolipoprotein E by gene amplification and cleavage with
Hhal. J Lipid Res 31, 545-548.
[31] Medina-Remo´n A, Barrionuevo-Gonza´lez A, Zamora-Ros
R, Andre´s-Lacueva C, Estruch R, Martı´nez-Gonza´lez MA,
Dı´ez-Espino J, Lamuela-Ravento´s RM (2009) Rapid Folin-
Ciocalteu method using microtiter 96-well plate cartridges for
solid phase extraction to assess urinary total phenolic com-
pounds as a biomarker of total polyphenol intake. Anal Chim
Acta 634, 54-60.
[32] Zamora-Ros R, Rabassa M, Cherubini A, Urpi-Sarda M, Llo-
rach R, Bandinelli S, Ferrucci L, Andres-Lacueva C (2011)
Comparison of 24-h volume and creatinine-corrected total uri-
nary polyphenol as a biomarker of total dietary polyphenols
in the Invecchiare In CHIANTI study. Anal Chim Acta 704,
110-115.
[33] Hamilton M (1967) Development of a rating scale for primary
depressive illness. Br J Soc Clin Psychol 6, 278-296.
[34] Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental
state”. A practical method for grading the cognitive state of
patients for the clinician. J Psychiatr Res 12, 189-198.
[35] Rey A (1964) L’examen Clinique en Psychologie, Presses
Universitaires de France, Paris.
[36] Wechsler D (1945) A standardized memory scale for clinical
use. J Psychol 19, 87-95.
[37] Ramier AM, Hecaen H (1970) Roˆle respectif des atteintes
frontales et de la late´ralisation le´sionnelle dans les de´ficits de
la fluence verbale. Rev Neur 123, 17-22.
[38] Wechsler D (1999) Escala de inteligencia de Wechsler para
adultos-III (WAIS III), TEA Ediciones, Madrid.
[39] D’Elia LF, Satz P, Uchiyama CL, White T (1994)ColorTrails:
Professional manual, Psychological assessment resources,
Odessa (Florida).
[40] Lopez-Miranda J, Perez-Jimenez F, Ros E, De Caterina R,
Badimon L, Covas MI, Escrich E, Ordovas JM, Soriguer
F, Abia R, de la Lastra CA, Battino M, Corella D,
Chamorro-Quiros J, Delgado-Lista J, Giugliano D, Esposito
K, Estruch R, Fernandez-Real JM, Gaforio JJ, La Vec-
chia C, Lairon D, Lopez-Segura F, Mata P, Menendez
JA, Muriana FJ, Osada J, Panagiotakos DB, Paniagua JA,
Perez-Martinez P, Perona J, Peinado MA, Pineda-Priego
M, Poulsen HE, Quiles JL, Ramirez-Tortosa MC, Ruano
J, Serra-Majem L, Sola R, Solanas M, Solfrizzi V, de la
Torre-Fornell R, Trichopoulou A, Uceda M, Villalba-Montoro
JM, Villar-Ortiz JR, Visioli F, Yiannakouris N (2010) Olive
oil and health: Summary of the II International Confer-
ence on Olive Oil and Health consensus report, Jae´n and
Co´rdoba (Spain) 2008. Nutr Metab Cardiovasc Dis 20, 284-
294.
[41] Ros E (2009) Nuts and novel biomarkers of cardiovascular
disease. Am J Clin Nutr 89, S1649-S1656.
[42] Ortega RM, Requejo AM, Andres P, Lo´pez-Sobaler AM,
Quintas ME, Redondo MR, Navia B, Rivas T (1997) Dietary
intake and cognitive function in a group of elderly people. Am
J Clin Nutr 66, 803-809.
[43] Solfrizzi V, Panza F, Torres F, Mastroianni F, Del Parigi A,
Venezia A, Capurso A (1999) High monounsaturated fatty
acid intake protects against age-related cognitive decline.
Neurology 52, 1563-1569.
[44] Solfrizzi V, Colacicco AM, D’Introno A, Capurso C, Del
Parigi A, Capurso SA, Argentieri G, Capurso A, Panza F
(2006) Dietary fatty acids intakes and rate of mild cognitive
impairment. The Italian Longitudinal Study on Aging. Exp
Gerontol 41, 619-627.
[45] Psaltopoulou T, Kyrozis A, Stathopoulos P, Trichopoulos D,
Vassilopoulos D, Trichopoulou A (2008) Diet, physical activ-
ity and cognitive impairment among elders: The EPIC-Greece
cohort (European Prospective Investigation in Cancer and
Nutrition). Public Health Nutr 11, 1054-1062.
[46] Cherbuin N, Astey KJ (2011) The Mediterranean diet is not
related to cognitive change in a large prospective investiga-
tion: The PATH Through Life Study. Am JGeriatr Psychiatry,
doi:10.1097/JGP.0b013e31823032a9.
[47] Berr C, Portet F, Carriere I, Akbaraly TN, Feart C, Gourlet V,
Combe N, Barberger-Gateau P, Ritchie K (2009) Olive oil and
cognition: Results from the Three-City study. Dement Geriatr
Cogn Disord 28, 357-364.
[48] Halvorsen BL, Holte K, Myhrstad MC, Barikmo I, Hvattum
E, Remberg SF, Wold AB, Haffner K, Baugerod H, Andersen
LF, Moskaug JO, Jacobs DR, Blomhoff R (2002) A systematic
screening of total antioxidants in dietary plants. J Nutr 132,
461-471.
[49] Kelly JH Jr, Sabate´ J (2006) Nuts and coronary heart disease,
an epidemiological perspective. Br J Nutr 96, S61-S67.
[50] Sabate´ J, Oda K, Ros E (2010) Nut consumption and blood
lipid levels. A pooled analysis of 25 intervention trials. Arch
Intern Med 170, 821-827.
[51] Nooyens ACJ, Bueno-de-Mesquita HB, van Boxtel MPJ, van
Gelder BM, Verhagen H, Verschuren WMM (2011) Fruit and
vegetable intake and cognitive decline in middle-aged men
and women: The Doetinchem Cohort Study. Br J Nutr 106,
752-761.
[52] Willis LM, Shukitt-Hale B, Cheng V, Joseph JA (2009) Dose-
dependent effects of walnuts on motor and cognitive function
in aged rats. Br J Nutr 101, 1140-1144.
[53] Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA
(2011) Association of alcohol consumption with selected
cardiovascular diseases outcomes: A systematic review and
meta-analysis. BMJ 342, d671.
[54] Covas MI, Gambert P, Fito´ M, de la Torre R (2010) Wine
and oxidative stress: Up-to-date evidence of the effects of
moderate wine consumption on oxidative damage in humans.
Atherosclerosis 208, 297-304.
[55] Peters R, Peters J, Warner J, Beckett N, Bulpitt C (2008)
Alcohol, dementia and cognitive decline in the elderly:
A systematic review. Age Ageing 37, 505-512.
[56] Panza F, Capurso C, D’Introno A, Colacicco AM, Frisardi
V, Lorusso M, Santamato A, Seripa D, Pilotto A, Scafato
E, Vendemiale G, Capurso A, Solfrizzi V (2009) Alcohol
drinking, cognitive functions in older age, predementia, and
dementia syndromes. J Alzheimers Dis 17, 7-31.
[57] Eskelinen MH, Kivipelto M (2010) Caffeine as a protective
factor in dementia and Alzheimer’s disease. J Alzheimers Dis
20, 167-174.
[58] Joseph JA, Shukitt-Hale B, Casadesus G (2005) Reversing
the deleterious effects of aging on neuronal communication
and behavior: Beneficial properties of fruit polyphenolic com-
pounds. Am J Clin Nutr 81, 313S-316S.
[59] Esposito E, Rotilio D, Di Mateo V, Di Giulio C, Cacchio M,
Algeri S (2002) A review of specific dietary antioxidants and
the effects on biochemical mechanisms related to neurode-
generative processes. Neurobiol Aging 23, 719-735.
[60] Kesse-Guyot E, Fezeu L, Jeandel C, Ferry M, Andreeva V,
Amieva H, Hercberg S, Galan P (2011) French adults’ cogni-
782 C. Valls-Pedret et al. / Polyphenol-Rich Foods and Cognition in Aging
tive performance after daily supplementation with antioxidant
vitamins and minerals at nutritional doses: A post hoc analysis
of the Supplementation in Vitamins and Mineral Antioxidants
(SU.VI.MAX) trial. Am J Clin Nutr 94, 892-899.
[61] Krikorian R, Nash TA, Shidler MD, Shukitt-Hale B, Joseph JA
(2010) Concord grape juice supplementation improves mem-
ory function in older adults with mild cognitive impairment.
Br J Nutr 103, 730-734.
[62] Droge W, Schipper HM (2007) Oxidative stress and aberrant
signalling in aging and cognitive decline. Aging Cell 6, 361-
370.
[63] Joseph JA, Cole G, Head E, Ingram D (2009) Nutrition, brain
aging, and neurodegeneration. J Neurosci 29, 12795-12801.
